The U.S. Food and Drug Administration (FDA) recently denied two petitions—one from pro-life group Students for Life, and one from the American College of Obstetricians and Gynecologists (ACOG)—regarding an abortion pill, marking the latest move in efforts to determine regulation over chemical abortion.
Chemical abortion, also referred to by other terms such as “abortion by medication,” is the most popular method of abortion in the United States, comprising more than half of total U.S. abortions.
The abortion pill of concern in the petitions, mifepristone, is the first of a two-drug regimen designed to kill an unborn child in pregnancies up to 10 weeks after conception….